Invus Advisors 13F annual report

Invus Advisors is an investment fund managing more than $182 million ran by Carmen Taton. There are currently 8 companies in Mrs. Taton’s portfolio. The largest investments include Coupang and Arcus Biosciences Inc, together worth $93 million.

$182 million Assets Under Management (AUM)

As of 7th November 2022, Invus Advisors’s top holding is 3,046,571 shares of Coupang currently worth over $50.8 million and making up 27.9% of the portfolio value.Relative to the number of outstanding shares of Coupang, Invus Advisors owns more than approximately 0.1% of the company.In addition, the fund holds 1,612,077 shares of Arcus Biosciences Inc worth $42.2 million, whose value fell approximately 0.1% in the past six months. The third-largest holding is NovoCure Ltd worth $26.7 million and the next is Nu Hldgs Ltd worth $24.6 million, with 5,582,950 shares owned.

Currently, Invus Advisors's portfolio is worth at least $182 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Invus Advisors

The Invus Advisors office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Carmen Taton serves as the Chief Compliance Officer/Chief Financial Officer at Invus Advisors.